FDA Inspection 1229751 — Rhode Island Blood Center, a Division of New York Blood Center, Inc. Warwick Donor Center
The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc. Warwick Donor Center on January 5, 2024 in Warwick, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 5, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Warwick, RI (United States)